Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorOslo University Hospital
About this trial
Celiac disease is a disorder commonly diagnosed during childhood. The treatment is a lifelong gluten-free diet. Both the condition and the diet can influence the children's physical and emotional well-being.
The main goal of this observational study is to learn about nutritional status in a group of children with celiac disease compared to a group of healthy children.
The nutritional assessment includes information on diet, biochemical measurement, and body composition. Quality of life will also be assessed.
The study can contribute to ensure good health and well-being in children on a gluten-free diet.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
eating a regular diet
Disqualifiers
None
Trial population
Age: 6-18 years
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
160 Participants
are grouped into 2 trial groupsGroup A: Celiac disease
Group B: Healthy
Trial outcomes
Primary outcomes
1
Iron deficiency will be assessed from hemoglobin and ferritin in children with celiac disease and in healthy children. Differences in the prevalences of iron deficiency between children with celiac disease and healthy children will be described.
Blood samples will be analyzed for blood hemoglobin and serum ferritin.
Time frame
All participants will be assessed once. The study time frame is from August 2024 until December 2025.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Oslo University Hospital
Lead sponsor
University of Oslo
Collaborator
Source ClinicalTrials.gov